Lennon RP, Griffin C, Miller EL, Dong H, Rabago D, Zgierska AE. Norovirus infections drop 49% in the United States with strict COVID-19 public health interventions. Acta Med Acad. 2020 Dec;49(3):278-80. doi: 0.5644/ama2006-124.317
Reau N, Hamzeh FM, Lentz E, Zhou X, Jensen D. Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin. J Viral Hepat. 2012 Feb;19(2):94-102.